Teachers College, Columbia University
Trial Pipeline
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
NCT07488338
Readiness and Progress in Emotion Regulation Therapy
NCT07478393
Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)
NCT07036406
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
NCT06540989
School Violence Exposure as an Adverse Childhood Experience
NCT06153316
Brief Interventions for Coping with Distress
NCT05779761
Rehabilitation of Airway Protection in Parkinson's Disease
NCT05700825
Robotic TruST-Postural Intervention for Children With Cerebral Palsy
NCT04897347
HABIT-ILE + FST in Children With SMA
NCT07223320
Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia
NCT05826171
An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy
NCT05590741
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
NCT05157802
Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)
NCT04922190
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease
NCT03696589
Resistance Training as an Aid to Smoking Cessation Treatment
NCT01951456
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 30 |
Therapeutic Areas
What the Pipeline for Teachers College, Columbia University Shows
According to the ClinicalTrials.gov registry, Teachers College, Columbia University is linked to 71 US clinical trials across every stage of research activity. Of those, 64 studies are currently recruiting — about 90% of the sponsor's indexed portfolio — and 2 are already marked complete, representing roughly 3% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Teachers College, Columbia University reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 34 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Teachers College, Columbia University is Distress, Emotional with 3 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.